TrialBMC infectious diseases2025

Prophylaxis for renal patients at risk of COVID-19 infection: results from the intranasal niclosamide randomised, double blinded, placebo controlled arm of the PROTECT-V platform trial.

Toby J L Humphrey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.